% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-08-24}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 85.

\begin{enumerate}[leftmargin=*]
\item Wawrzczak-Bargieła Agnieszka, Jelonek-Kozioł Małgorzata, Kumorek Weronika, Bilecki Wiktor, Maćkowiak Marzena (2026). \textit{Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex}. Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00213-026-07132-6}{doi:10.1007/s00213-026-07132-6}.
\item Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y (2026). \textit{Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-026-07110-y}{doi:10.1007/s00213-026-07110-y}.
\item St Pierre M, Argento E, Cates J, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Paschall SA, Kuypers KPC, Rootman J, Walsh Z (2026). \textit{Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06913-9}{doi:10.1007/s00213-025-06913-9}.
\item Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ (2026). \textit{Provider perspectives on challenges in treatment during psychedelic therapy.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06907-7}{doi:10.1007/s00213-025-06907-7}.
\item Atiq Mazen A., Weisman Eli, Guerra Rodrigo B., Martinez Luis Luna, Yaden David B., Barrett Frederick S., Nayak Sandeep, Sayali Ceyda (2026). \textit{Psilocybin-induced neurocardiogenic syncope: a case report}. Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00213-026-07079-8}{doi:10.1007/s00213-026-07079-8}.
\item Anne-Fiona Griesfeller, Lotte Kooman, Lilian Kloft-Heller, Samuli Kangaslampi, Johannes G Ramaekers, Henry Otgaar (2026). \textit{Evaluating the evidence for repressed memory recovery in psychedelic contexts}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-026-07076-x}{doi:10.1007/s00213-026-07076-x}.
\item Kangaslampi S, Lietz M (2025). \textit{Psychedelics and autobiographical memory - six open questions.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06771-5}{doi:10.1007/s00213-025-06771-5}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD (2025). \textit{Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06788-w}{doi:10.1007/s00213-025-06788-w}.
\item McGriff SA, Hecker JC, Maitland AD, Partilla JS, Baumann MH, Glatfelter GC (2025). \textit{Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06795-x}{doi:10.1007/s00213-025-06795-x}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD (2025). \textit{Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06818-7}{doi:10.1007/s00213-025-06818-7}.
\item Jussi Jylkkä, Aila Mustamo (2025). \textit{Psychedelic researchers’ own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-025-06871-2}{doi:10.1007/s00213-025-06871-2}.
\item Ley L, Liechti ME, Becker AM, Straumann I, Klaiber A, Holze F, Vogt SB, Arikci D, Schmid Y (2025). \textit{Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06772-4}{doi:10.1007/s00213-025-06772-4}.
\item Rahbarnia A, Li Z, Fletcher PJ (2025). \textit{Effects of psilocybin, the 5-HT receptor agonist TCB-2, and the 5-HT receptor antagonist M100907 on visual attention in male mice in the continuous performance test.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-023-06474-9}{doi:10.1007/s00213-023-06474-9}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A (2025). \textit{Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06644-3}{doi:10.1007/s00213-024-06644-3}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A (2025). \textit{Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06654-1}{doi:10.1007/s00213-024-06654-1}.
\item Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M, Enriquez-Geppert S (2025). \textit{Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06742-2}{doi:10.1007/s00213-024-06742-2}.
\item Irrmischer M, Puxty D, Yıldırım BO, Deijen JB, Engelbregt H (2025). \textit{Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06733-3}{doi:10.1007/s00213-024-06733-3}.
\item Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS (2025). \textit{Practical considerations in the establishment of psychedelic research programs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06722-6}{doi:10.1007/s00213-024-06722-6}.
\item Sakai K, Bradley ER, Zamaria JA, Agin-Liebes G, Kelley DP, Fish A, Martini V, Ferris MC, Morton E, Michalak EE, O'Donovan A, Woolley JD (2024). \textit{Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06585-x}{doi:10.1007/s00213-024-06585-x}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Soliman PS, Curley DE, Capone C, Eaton E, Haass-Koffler CL (2024). \textit{In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06598-6}{doi:10.1007/s00213-024-06598-6}.
\item Benvenuti F, Colombo D, Soverchia L, Cannella N, Domi E, Ciccocioppo R (2023). \textit{Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-023-06384-w}{doi:10.1007/s00213-023-06384-w}.
\item Buzzelli V, Carbone E, Manduca A, Schiavi S, Feo A, Perederiy JV, Ambert KH, Hausman M, Trezza V (2023). \textit{Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06286-3}{doi:10.1007/s00213-022-06286-3}.
\item Meccia J, Lopez J, Bagot RC (2023). \textit{Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06297-0}{doi:10.1007/s00213-022-06297-0}.
\item Hartogsohn I, Petranker R (2022). \textit{Set and setting in microdosing: an oft-overlooked principle.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06249-8}{doi:10.1007/s00213-022-06249-8}.
\item Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L (2022). \textit{The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06187-5}{doi:10.1007/s00213-022-06187-5}.
\item Butler M, Jelen L, Rucker J (2022). \textit{Expectancy in placebo-controlled trials of psychedelics: if so, so what?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06221-6}{doi:10.1007/s00213-022-06221-6}.
\item Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E (2022). \textit{Natural language signatures of psilocybin microdosing.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06170-0}{doi:10.1007/s00213-022-06170-0}.
\item van Elk M, Fejer G, Lempe P, Prochazckova L, Kuchar M, Hajkova K, Marschall J (2022). \textit{Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05857-0}{doi:10.1007/s00213-021-05857-0}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J (2022). \textit{Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05913-9}{doi:10.1007/s00213-021-05913-9}.
\item Murray CH, Tare I, Perry CM, Malina M, Lee R, de Wit H (2022). \textit{Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05991-9}{doi:10.1007/s00213-021-05991-9}.
\item Bender D, Hellerstein DJ (2022). \textit{Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-06049-6}{doi:10.1007/s00213-021-06049-6}.
\item Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S (2022). \textit{Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06066-z}{doi:10.1007/s00213-022-06066-z}.
\item Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J (2022). \textit{Effects of the 5-HT receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06092-x}{doi:10.1007/s00213-022-06092-x}.
\item Popik Piotr, Hogendorf Adam, Bugno Ryszard, Khoo Shaun Yon-Seng, Zajdel Pawel, Malikowska-Racia Natalia, Nikiforuk Agnieszka, Golebiowska Joanna (2022). \textit{Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats}. Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00213-021-06020-5}{doi:10.1007/s00213-021-06020-5}.
\item Sarparast A, Thomas K, Malcolm B, Stauffer CS (2022). \textit{Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06083-y}{doi:10.1007/s00213-022-06083-y}.
\item van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH (2022). \textit{How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06106-8}{doi:10.1007/s00213-022-06106-8}.
\item Hase A, Erdmann M, Limbach V, Hasler G (2022). \textit{Analysis of recreational psychedelic substance use experiences classified by substance.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06062-3}{doi:10.1007/s00213-022-06062-3}.
\item Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA (2022). \textit{Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-06027-y}{doi:10.1007/s00213-021-06027-y}.
\item Joanna Kuc, Hannes Kettner, Fernando E. Rosas, David Erritzøe, Eline Haijen, Mendel Kaelen, David Nutt, Robin Carhart-Harris (2021). \textit{Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-021-05999-1}{doi:10.1007/s00213-021-05999-1}.
\item Healy CJ (2021). \textit{The acute effects of classic psychedelics on memory in humans.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05756-w}{doi:10.1007/s00213-020-05756-w}.
\item Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J (2021). \textit{Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05719-1}{doi:10.1007/s00213-020-05719-1}.
\item Netzband N, Ruffell S, Linton S, Tsang WF, Wolff T (2020). \textit{Modulatory effects of ayahuasca on personality structure in a traditional framework.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05601-0}{doi:10.1007/s00213-020-05601-0}.
\item Carbonaro TM, Johnson MW, Griffiths RR (2020). \textit{Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05533-9}{doi:10.1007/s00213-020-05533-9}.
\item Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M (2020). \textit{Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05477-0}{doi:10.1007/s00213-020-05477-0}.
\item Olson JA, Suissa-Rocheleau L, Lifshitz M, Raz A, Veissière SPL (2020). \textit{Tripping on nothing: placebo psychedelics and contextual factors.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05464-5}{doi:10.1007/s00213-020-05464-5}.
\item Moreton SG, Szalla L, Menzies RE, Arena AF (2020). \textit{Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05391-0}{doi:10.1007/s00213-019-05391-0}.
\item Russ SL, Carhart-Harris RL, Maruyama G, Elliott MS (2019). \textit{Replication and extension of a model predicting response to psilocybin.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05279-z}{doi:10.1007/s00213-019-05279-z}.
\item Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS (2019). \textit{Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-018-5106-2}{doi:10.1007/s00213-018-5106-2}.
\item Jalal B (2018). \textit{The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-018-5042-1}{doi:10.1007/s00213-018-5042-1}.
\item Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-018-4981-x}{doi:10.1007/s00213-018-4981-x}.
\item Sessa B (2018). \textit{The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4713-7}{doi:10.1007/s00213-017-4713-7}.
\item Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL (2018). \textit{Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4754-y}{doi:10.1007/s00213-017-4754-y}.
\item Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4769-4}{doi:10.1007/s00213-017-4769-4}.
\item Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ (2018). \textit{Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4771-x}{doi:10.1007/s00213-017-4771-x}.
\item Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J, Horáček J, Balíková M, Griškova-Bulanova I, Danielová D, Vlček P, Mohr P, Brunovský M, Koudelka V, Páleníček T (2018). \textit{Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4807-2}{doi:10.1007/s00213-017-4807-2}.
\item Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R (2018). \textit{The hidden therapist: evidence for a central role of music in psychedelic therapy.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4820-5}{doi:10.1007/s00213-017-4820-5}.
\item Liechti ME, Dolder PC, Schmid Y (2017). \textit{Alterations of consciousness and mystical-type experiences after acute LSD in humans.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-016-4453-0}{doi:10.1007/s00213-016-4453-0}.
\item Kometer M, Pokorny T, Seifritz E, Volleinweider FX (2015). \textit{Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-015-4026-7}{doi:10.1007/s00213-015-4026-7}.
\item Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F (2013). \textit{The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-012-2811-0}{doi:10.1007/s00213-012-2811-0}.
\item Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR (2012). \textit{High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-012-2680-6}{doi:10.1007/s00213-012-2680-6}.
\item Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R (2011). \textit{Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-011-2358-5}{doi:10.1007/s00213-011-2358-5}.
\item Jan RK, Lin JC, Lee H, Sheridan JL, Kydd RR, Kirk IJ, Russell BR (2010). \textit{Determining the subjective effects of TFMPP in human males.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-010-1911-y}{doi:10.1007/s00213-010-1911-y}.
\item Butelman ER, Rus S, Prisinzano TE, Kreek MJ (2010). \textit{The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-009-1771-5}{doi:10.1007/s00213-009-1771-5}.
\item J.C. Winter (2008). \textit{Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-008-1356-8}{doi:10.1007/s00213-008-1356-8}.
\item Danuta Marona-Lewicka, Benjamin R. Chemel, David E. Nichols (2008). \textit{Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-008-1238-0}{doi:10.1007/s00213-008-1238-0}.
\item Heekeren K, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E (2008). \textit{Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-008-1129-4}{doi:10.1007/s00213-008-1129-4}.
\item Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX (2007). \textit{Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-007-0930-9}{doi:10.1007/s00213-007-0930-9}.
\item Griffiths RR, Richards WA, McCann U, Jesse R (2006). \textit{Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-006-0457-5}{doi:10.1007/s00213-006-0457-5}.
\item Herbert D. Kleber (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0461-9}{doi:10.1007/s00213-006-0461-9}.
\item Charles R. Schuster (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0460-x}{doi:10.1007/s00213-006-0460-x}.
\item David E. Nichols (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0458-4}{doi:10.1007/s00213-006-0458-4}.
\item Solomon H. Snyder (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0459-3}{doi:10.1007/s00213-006-0459-3}.
\item Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004). \textit{Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-003-1640-6}{doi:10.1007/s00213-003-1640-6}.
\item Riba J, Rodríguez-Fornells A, Barbanoj MJ (2002). \textit{Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-002-1237-5}{doi:10.1007/s00213-002-1237-5}.
\item Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA, Lindenblatt H, Hermle L, Spitzer M, Sass H (1999). \textit{Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s002130050860}{doi:10.1007/s002130050860}.
\item Koerner J, Appel JB (1982). \textit{Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00435266}{doi:10.1007/bf00435266}.
\item Geyer MA, Light RK, Rose GJ, Petersen LR, Horwitt DD, Adams LM, Hawkins RL (1979). \textit{A characteristic effect of hallucinogens on investigatory responding in rats.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00491975}{doi:10.1007/bf00491975}.
\item Sbordone RJ, Wingard JA, Gorelick DA, Elliott ML (1979). \textit{Severe aggression in rats induced by mescaline but not other hallucinogens.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00428319}{doi:10.1007/bf00428319}.
\item Whitaker PM, Seeman P (1978). \textit{High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00428022}{doi:10.1007/bf00428022}.
\item Meltzer HY, Fessler RG, Simonovic M, Fang VS (1978). \textit{Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00432847}{doi:10.1007/bf00432847}.
\item Castellano Claudio (1978). \textit{Effects of mescaline and psilocin on acquisition, consolidation, and performance of light-dark discrimination in two inbred strains of mice}. Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1007/bf00427746}{doi:10.1007/bf00427746}.
\item Francesca Bermond, Julien Bert (1969). \textit{Action de la psilocybine sur le comportement d'un cercopithecinae papio-papio}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/bf00407043}{doi:10.1007/bf00407043}.
\end{enumerate}
\end{document}
